About
Technology
Issues
FAQ
Links
Official Page
Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non–Small Cell Lung Cancer with
EGFR
Exon 20 Insertion Mutations from a Phase I/II Trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.